NO973367L - Fremgangsmåte for å inhibere miljömessige östrogen - Google Patents
Fremgangsmåte for å inhibere miljömessige östrogenInfo
- Publication number
- NO973367L NO973367L NO973367A NO973367A NO973367L NO 973367 L NO973367 L NO 973367L NO 973367 A NO973367 A NO 973367A NO 973367 A NO973367 A NO 973367A NO 973367 L NO973367 L NO 973367L
- Authority
- NO
- Norway
- Prior art keywords
- inhibiting
- environmental estrogen
- inhibiting environmental
- estrogen
- hexemethylenimino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/378,229 US5521214A (en) | 1995-01-25 | 1995-01-25 | Methods of inhibiting environmental estrogens |
PCT/US1996/000902 WO1996022771A1 (en) | 1995-01-25 | 1996-01-22 | Methods of inhibiting environmental estrogens |
Publications (2)
Publication Number | Publication Date |
---|---|
NO973367D0 NO973367D0 (no) | 1997-07-21 |
NO973367L true NO973367L (no) | 1997-07-21 |
Family
ID=23492278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO973367A NO973367L (no) | 1995-01-25 | 1997-07-21 | Fremgangsmåte for å inhibere miljömessige östrogen |
Country Status (13)
Country | Link |
---|---|
US (1) | US5521214A (ru) |
EP (1) | EP0806950A4 (ru) |
JP (1) | JPH10512886A (ru) |
KR (1) | KR19980701589A (ru) |
CN (1) | CN1169116A (ru) |
AU (1) | AU699678B2 (ru) |
CA (1) | CA2210940A1 (ru) |
CZ (1) | CZ233797A3 (ru) |
EA (1) | EA199700136A1 (ru) |
FI (1) | FI973095A (ru) |
HU (1) | HUP9800550A3 (ru) |
NO (1) | NO973367L (ru) |
WO (1) | WO1996022771A1 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9624800D0 (en) * | 1996-11-29 | 1997-01-15 | Lilly Co Eli | Methods of preventing breast cancer |
CA2219070C (en) * | 1996-10-30 | 2007-12-18 | Eli Lilly And Company | Methods of preventing breast cancer |
US5760030A (en) * | 1997-06-30 | 1998-06-02 | Eli Lilly And Company | Benzothiophene compounds and methods of use |
KR20020013533A (ko) | 1999-05-04 | 2002-02-20 | 앤드류 맥린 | 안드로겐 글리코사이드와 그것의 안드로겐 활성 |
EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
KR100334130B1 (ko) * | 2000-02-18 | 2002-04-26 | 정명식 | 에스트로겐 유사물질의 생물학적 분석방법 |
KR100368936B1 (ko) * | 2000-10-04 | 2003-01-24 | 주식회사 대웅 | 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제 |
ES2349093T3 (es) * | 2000-11-28 | 2010-12-27 | Mitsubishi Tanabe Pharma Corporation | Acelerador de excreción para un compuesto de cloro acumulativo. |
US7720727B2 (en) * | 2001-03-01 | 2010-05-18 | Fisher-Rosemount Systems, Inc. | Economic calculations in process control system |
DK3820874T3 (da) * | 2018-07-12 | 2022-12-12 | Lilly Co Eli | Selektive estrogenreceptornedbrydere |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
US5593987A (en) * | 1993-12-21 | 1997-01-14 | Eli Lilly And Company | Methods of inhibiting breast disorders |
US5451590A (en) * | 1993-12-21 | 1995-09-19 | Eli Lilly & Co. | Methods of inhibiting sexual precocity |
-
1995
- 1995-01-25 US US08/378,229 patent/US5521214A/en not_active Expired - Fee Related
-
1996
- 1996-01-22 CN CN96191595A patent/CN1169116A/zh active Pending
- 1996-01-22 CA CA002210940A patent/CA2210940A1/en not_active Abandoned
- 1996-01-22 WO PCT/US1996/000902 patent/WO1996022771A1/en not_active Application Discontinuation
- 1996-01-22 KR KR1019970704981A patent/KR19980701589A/ko not_active Application Discontinuation
- 1996-01-22 HU HU9800550A patent/HUP9800550A3/hu unknown
- 1996-01-22 AU AU47649/96A patent/AU699678B2/en not_active Ceased
- 1996-01-22 EP EP96903635A patent/EP0806950A4/en not_active Withdrawn
- 1996-01-22 JP JP8522978A patent/JPH10512886A/ja active Pending
- 1996-01-22 CZ CZ972337A patent/CZ233797A3/cs unknown
-
1997
- 1997-07-21 NO NO973367A patent/NO973367L/no unknown
- 1997-07-23 FI FI973095A patent/FI973095A/fi unknown
- 1997-08-22 EA EA199700136A patent/EA199700136A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
AU699678B2 (en) | 1998-12-10 |
HUP9800550A2 (hu) | 1998-12-28 |
US5521214A (en) | 1996-05-28 |
JPH10512886A (ja) | 1998-12-08 |
MX9705537A (es) | 1997-10-31 |
KR19980701589A (ko) | 1998-05-15 |
FI973095A0 (fi) | 1997-07-23 |
EA199700136A1 (ru) | 1997-12-30 |
CN1169116A (zh) | 1997-12-31 |
CZ233797A3 (cs) | 1998-02-18 |
HUP9800550A3 (en) | 1999-10-28 |
NO973367D0 (no) | 1997-07-21 |
WO1996022771A1 (en) | 1996-08-01 |
AU4764996A (en) | 1996-08-14 |
EP0806950A1 (en) | 1997-11-19 |
EP0806950A4 (en) | 1999-01-07 |
CA2210940A1 (en) | 1996-08-01 |
FI973095A (fi) | 1997-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO973635L (no) | Fremgangsmåte for hemming av celle-celle adhesjon | |
NO971520L (no) | Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y | |
NO944928L (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
NO944919L (no) | Fremgangsmåte for å inhibere atrofi av huden eller vagina | |
NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
NO944914L (no) | Fremgangsmåte for å inhibere autoimmunsykdommer | |
MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
AU3408795A (en) | Methods of inhibiting viral replication | |
DK0659417T3 (da) | Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen | |
MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
NO973367L (no) | Fremgangsmåte for å inhibere miljömessige östrogen | |
NO944926L (no) | Fremgangsmåter for å inhibere myeloperoksidaseaktivitet | |
NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
NO944924L (no) | Fremgangsmåter for inhibering av Turner's syndrom | |
NO970786L (no) | Fremgangsmåte for hemming av benprotesedegradering | |
NO975738L (no) | Modulering av kalsiumkanaler | |
NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
NO973609L (no) | Fremgangsmåte for å inhibere effektene av IL-6 | |
NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin | |
NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter | |
NO970783L (no) | Fremgangsmåte for å hindre endometrialkreft | |
NO971029L (no) | Fremgangsmåter for hemming av endometriale metoser | |
NO944909L (no) | Fremgangsmåter for inhibering av mannlig infertilitet | |
NO975561L (no) | Kalsiumkanalantagonister |